A  	A  	 DT	O
systematic  	systematic  	 JJ	B-NP
comparison  	comparison  	 NN	I-NP
of  	of  	 IN	I-NP
rheumatoid  	rheumatoid  	 JJ	I-NP
arthritis  	arthritis  	 NN	I-NP
and  	and  	 CC	O
ankylosing  	ankylosing  	 JJ	B-NP
spondylitis 	spondylitis 	 NN	I-NP
:  	:  	 :	O
non-steroidal  	non-steroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
drugs  	drugs  	 NNS	I-NP
Non-steroidal  	Non-steroidal  	 JJ	I-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
drugs  	drugs  	 NNS	I-NP
( 	( 	 -LRB-	O
NSAIDs 	NSAIDs 	 NNP	B-NP
)  	)  	 -RRB-	O
play  	play  	 VBP	O
different  	different  	 JJ	O
roles  	roles  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
management  	management  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
rheumatoid  	rheumatoid  	 JJ	B-NP
arthritis  	arthritis  	 NN	I-NP
( 	( 	 -LRB-	O
RA 	RA 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
ankylosing  	ankylosing  	 JJ	B-NP
spondylitis  	spondylitis  	 NNS	I-NP
( 	( 	 -LRB-	O
AS 	AS 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
RA  	RA  	 NNP	B-NP
there  	there  	 EX	O
is  	is  	 VBZ	O
minimal  	minimal  	 JJ	O
evidence  	evidence  	 NN	O
that  	that  	 IN	O
NSAIDs  	NSAIDs  	 NNS	B-NP
are  	are  	 VBP	O
able  	able  	 JJ	O
to  	to  	 TO	O
alter  	alter  	 VB	O
the  	the  	 DT	O
course  	course  	 NN	O
of  	of  	 IN	O
disease  	disease  	 NN	O
or  	or  	 CC	O
prevent  	prevent  	 VB	O
joint  	joint  	 JJ	O
destruction  	destruction  	 NN	O
and 	and 	 CC	O
,  	,  	 ,	O
therefore 	therefore 	 RB	O
,  	,  	 ,	O
they  	they  	 PRP	O
should  	should  	 MD	O
mostly  	mostly  	 RB	O
be  	be  	 VB	O
used  	used  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
short-term  	short-term  	 JJ	O
bridging  	bridging  	 JJ	O
therapy 	therapy 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
contrast  	contrast  	 NN	O
to  	to  	 TO	O
RA 	RA 	 NNP	B-NP
,  	,  	 ,	O
in  	in  	 IN	O
AS  	AS  	 NNP	O
NSAIDs  	NSAIDs  	 NNP	B-NP
are  	are  	 VBP	O
considered  	considered  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
cornerstone  	cornerstone  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
not  	not  	 RB	O
only  	only  	 RB	O
because  	because  	 IN	O
of  	of  	 IN	O
a  	a  	 DT	O
high  	high  	 JJ	O
symptomatic  	symptomatic  	 JJ	B-NP
efficacy 	efficacy 	 NN	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
also  	also  	 RB	O
because  	because  	 IN	O
they  	they  	 PRP	O
might  	might  	 MD	O
even  	even  	 RB	O
retard  	retard  	 JJ	O
osteoproliferation  	osteoproliferation  	 NN	B-NP
and  	and  	 CC	O
radiographic  	radiographic  	 JJ	B-NP
progression 	progression 	 NN	I-NP
.  	.  	 .	O
Considering  	Considering  	 VBG	O
younger  	younger  	 JJR	O
age  	age  	 NN	O
of  	of  	 IN	O
AS  	AS  	 NNP	O
patients  	patients  	 NNS	O
and  	and  	 CC	O
lower  	lower  	 JJR	O
prevalence  	prevalence  	 NN	O
of  	of  	 IN	O
comorbidities 	comorbidities 	 NN	B-NP
,  	,  	 ,	O
they  	they  	 PRP	O
are  	are  	 VBP	O
probably  	probably  	 RB	O
at  	at  	 IN	O
lower  	lower  	 JJR	O
risk  	risk  	 NN	O
for  	for  	 IN	O
cardiovascular  	cardiovascular  	 JJ	O
and  	and  	 CC	O
gastrointestinal  	gastrointestinal  	 JJ	B-NP
side  	side  	 NN	I-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	O
short-  	short-  	 JJ	O
and  	and  	 CC	O
long-term  	long-term  	 JJ	O
NSAID  	NSAID  	 NNP	B-NP
therapy  	therapy  	 NN	I-NP
in  	in  	 IN	O
comparison  	comparison  	 NN	O
to  	to  	 TO	O
RA 	RA 	 NNP	B-NP
.  	.  	 .	O
